A, the loss of acute sensitization to A-nociceptor stimulation 3 h after complete Freund's adjuvant (CFA) injection was partially reversed by the intrathecal injection of the noradrenergic α-2 receptor antagonist yohimbine [Mann–Whitney U test, *P < 0.05; n = 7 CFA (3 h), n = 5 yoh]. B, the loss of acute sensitization to C-nociceptor stimulation 3 h after CFA injection was reversed by yohimbine [Mann–Whitney U test, *P < 0.05; n = 8 CFA (3 h), n = 5 yoh]. C, D, systemic administration of the pan-opioid antagonist, naloxone, had no effect on either A-nociceptor evoked withdrawals (CFA, n = 5; CFA + nal, n = 6) (C) or C-nociceptor evoked withdrawals (CFA, n = 5; CFA + nal, n = 6) (D).